| | GLA, RPL36A-HNRNPH2 (T412fs +1 more) | Deletion (frameshift variant +2 more) | not provided +1 more | |
| | GLA, RPL36A-HNRNPH2 (W399S +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +4 more | |
| | GLA, RPL36A-HNRNPH2 (L394P +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (Y365N +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +3 more | |
| | GLA, RPL36A-HNRNPH2 (R363H +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (R363C +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +1 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (Q357fs +1 more) | Duplication (frameshift variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (R383Q) | Single nucleotide variant (missense variant +2 more) | not provided +1 more | |
| | | Single nucleotide variant (intron variant) | Fabry disease +2 more | |
| | GLA, RPL36A-HNRNPH2 (V316A +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | RPL36A-HNRNPH2, GLA (R301Q +1 more) | Single nucleotide variant (missense variant +2 more) | Primary familial hypertrophic cardiomyopathy +3 more | |
| | GLA, RPL36A-HNRNPH2 (M296I +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease | |
| | GLA, RPL36A-HNRNPH2 (M296V +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +1 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (W277G +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +2 more | |
| | GLA, RPL36A-HNRNPH2 (N272S +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (M267I +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +1 more | |
| | GLA, RPL36A-HNRNPH2 (W286L) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (D244H +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease | |
| | GLA, RPL36A-HNRNPH2 (I242V +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | |
| | GLA, RPL36A-HNRNPH2 (K240fs +1 more) | Deletion (frameshift variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (R227* +1 more) | Single nucleotide variant (nonsense +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (C223Y +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (R220Q +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiomyopathy +1 more | |
| | GLA, RPL36A-HNRNPH2 (R220* +1 more) | Single nucleotide variant (nonsense +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (N215S +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiomyopathy +4 more | |
| | | Single nucleotide variant (intron variant +1 more) | Fabry disease +1 more | |
| | | Single nucleotide variant (intron variant) | Fabry disease +1 more | |
| | | Single nucleotide variant (intron variant) | GLA-related disorder +2 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (L206F +1 more) | Single nucleotide variant (missense variant +2 more) | Primary familial hypertrophic cardiomyopathy +2 more | |
| | RPL36A-HNRNPH2, GLA (G183D +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (D175E +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | |
| | GLA, RPL36A-HNRNPH2 (C172Y +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (W162* +1 more) | Single nucleotide variant (nonsense +2 more) | Fabry disease +1 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (K140T +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | |
| | GLA, HNRNPH2 +1 more (R112H +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (R153C) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | |
| | RPL36A-HNRNPH2, GLA (E87K +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease | |
| | GLA, RPL36A-HNRNPH2 (G80D +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant +1 more) | Fabry disease +1 more | |
| | | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (T41S) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | |
| | GLA, RPL36A-HNRNPH2 (P40S) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (D25N) | Single nucleotide variant (missense variant +2 more) | Hypertrophic cardiomyopathy 1 +1 more | |
| | GLA, RPL36A-HNRNPH2 (A20D) | Single nucleotide variant (missense variant +2 more) | Fabry disease | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (G11V) | Single nucleotide variant (missense variant +2 more) | Fabry disease | |
| | | Single nucleotide variant (nonsense +2 more) | Fabry disease +1 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | not specified +1 more | |
| | | Single nucleotide variant (intron variant) | Fabry disease +1 more | |